学术探索
学术期刊
新闻热点
数据分析
智能评审

LIPOSOMAL DRUG DELIVERY - ADVANTAGES AND LIMITATIONS FROM A CLINICAL PHARMACOKINETIC AND THERAPEUTIC PERSPECTIVE

被引：108
作者：
FIELDING, RM [1 ]
机构：
[1] LIPOSOME TECHNOL INC, PHARMACOL TOXICOL GRP, MENLO PK, CA USA
来源：
CLINICAL PHARMACOKINETICS | 1991年 / 21卷 / 03期
关键词：
D O I：
10.2165/00003088-199121030-00001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：155 / 164
页数：10
相关论文
共 81 条
  • [1] LIPOSOME DISPOSITION INVIVO .6. DELIVERY TO THE LUNG
    ABRA, RM
    HUNT, CA
    LAU, DT
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (02) : 203 - 206
  • [2] AHMAD I, 1989, INDIAN J BIOCHEM BIO, V26, P351
  • [3] LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES
    ALLEN, TM
    HANSEN, C
    RUTLEDGE, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) : 27 - 35
  • [4] ALVING CR, 1986, MED APPLICATION LIPO, P105
  • [5] [Anonymous], 1988, LIPOSOMES DRUG CARRI
  • [6] LIPOSOMES WITH ENTRAPPED DOXORUBICIN EXHIBIT EXTENDED BLOOD RESIDENCE TIMES
    BALLY, MB
    NAYAR, R
    MASIN, D
    HOPE, MJ
    CULLIS, PR
    MAYER, LD
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1023 (01) : 133 - 139
  • [7] BARD DR, 1985, CLIN EXP RHEUMATOL, V3, P237
  • [8] INTERACTIONS OF LIPOSOMES WITH SERUM-PROTEINS
    BONTE, F
    JULIANO, RL
    [J]. CHEMISTRY AND PHYSICS OF LIPIDS, 1986, 40 (2-4) : 359 - 372
  • [9] BRADFIELD JWB, 1984, MICROSPHERES DRUG TH, P25
  • [10] DOXORUBICIN AND 5-FLUOROURACIL PLASMA-CONCENTRATIONS AND DETECTABILITY IN PAROTID-SALIVA
    CELIO, LA
    DIGREGORIO, GJ
    RUCH, E
    PACE, J
    PIRAINO, AJ
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (02) : 261 - 266
123456789